NCT/Study#

CMX-DS-003

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of dociparstat sodium in combination with standard chemotherapy for the treatment of ACTIVEly-diagnosed acute myeloid leukemia

A randomized, double-blind, placebo-controlled study to evaluate the efficacy
and safety of dociparstat sodium in combination with standard chemotherapy
for the treatment of ACTIVEly-diagnosed acute myeloid leukemia

DISEASE GROUP:
Leukemia
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: